GLM-5.1 is a new open weights reasoning model focused on coding, agentic engineering and long horizon execution. This deep ...

People shouldn't be able to move like Florida DT Caleb Banks at 6-6 and 327 pounds. That's a profile you bet on — but it's ...

For decades, scientists have tried and failed to explain how the force that binds the heart of atoms together really works.

I have a few things to say about the recent decision by a federal judge in Kentucky who ruled against the Horseracing ...

The Daghita arrest is solved. The broken U.S. Marshals system that made it possible isn't. Four procurement failures, an ...

The ExoLife Finder (ELF) looks like no telescope ever built. A spectacular crown of 15 five-meter mirrors perches atop a ...

Ty Simpson might be the most intriguing prospect in the 2026 NFL Draft, but how does the Alabama QB measure up against his ...

The rights to subsistence and development are the most fundamental human rights. While Japanese representatives declare at ...

Cutting Maintenance Costs and Extending Equipment Lifespan with Advanced Magnetic Drive Technology CALIFORNIA, CA, ...

KVS admission notification for 2026-27 not yet released. Admission process likely to start in March 2026. Two-phase cycle: Balvatika/Class 1 in March, Classes 2-12 in April. Did our AI summary help?

Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...